The EEA1 Knockout AGS Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human AGS gastric adenocarcinoma cell line, engineered to disrupt the EEA1 gene via CRISPR/Cas9-mediated gene disruption. This polyclonal knockout model provides a heterogeneous loss-of-function tool for investigating early endosome biology without the clonal selection inherent in monoclonal knockouts, enabling robust, population-level analyses of endocytic trafficking. The polyclonal format is particularly suited for assays where averaging across a cell pool reflects physiological variability, such as large-scale drug screening or signaling studies that require stable knockout in a cancer background. As a ready-to-use knockout resource, these cells facilitate rapid deployment in functional genomics and cell biology workflows, maintaining the parental line’s adherent growth characteristics and tumorigenic context.
The host AGS cell line originates from a human gastric adenocarcinoma, isolated from a stomach cancer patient, and has been widely employed as a model system for gastric cancer pathogenesis, drug response profiling, and host-pathogen interactions. AGS cells display properties typical of epithelial cancer cells, including dysregulated growth factor signaling, active membrane trafficking, and susceptibility to oncogenic transformation pathways. Their relevance to gastric cancer research is underscored by their utility in studying Helicobacter pylori infection mechanisms, chemotherapeutic agent sensitivity, and tumor cell invasion. Within this context, the EEA1 knockout polyclonal population offers a distinct platform to dissect endosomal functions that are frequently altered in cancer progression, without the confounding effects of single-cell clone adaptation.
EEA1 (Early Endosome Antigen 1) functions as a critical tethering factor on early endosomes, where it is recruited by the activated GTPase Rab5 and binds to the phosphoinositide PI3P, generated by class III PI3K. This dual interaction facilitates homotypic fusion of early endosomes, enabling the sorting and maturation of internalized cargo, including ligand?Creceptor complexes. EEA1 interacts with syntaxin 13 and endosomal SNARE proteins to drive membrane fusion, thereby regulating receptor recycling and degradation pathways. Upstream, activation of receptor tyrosine kinases such as EGFR stimulates Rab5 via guanine nucleotide exchange factors, leading to enhanced EEA1?CPI3P complex formation on endosomal membranes. Consequently, EEA1 bridges the sensing of active Rab5 to endosomal fusion machinery, coordinating endocytic trafficking with downstream signaling cascades such as the MAPK/ERK pathway, which is activated following receptor internalization and endosomal signaling platform assembly.
In AGS gastric adenocarcinoma cells, EEA1 knockout disrupts early endosome maturation, leading to defective receptor trafficking and altered signal transduction, particularly affecting pathways driven by growth factor receptors like EGFR. This disruption impairs the efficiency of receptor recycling to the plasma membrane and may prolong or attenuate downstream MAPK/ERK signaling, with potential consequences for cell proliferation, survival, and metabolic adaptation. Given that gastric cancers often exhibit aberrant EGFR signaling and endocytic pathway dysregulation, this knockout model provides a physiologically relevant background to study how endosomal dysfunction contributes to tumor phenotype. Furthermore, AGS cells are commonly used to investigate H. pylori virulence factor CagA, which exploits host endocytic machinery, making the EEA1 knockout polyclonal population a valuable tool to explore pathogen subversion of intracellular trafficking during infection.
This polyclonal knockout cell product is designed for a wide range of research applications, including endosomal trafficking dynamics, quantitative receptor internalization assays (e.g., transferrin uptake or pHrodo-labeled ligand uptake), and cancer signaling pathway dissection via phospho-ERK immunoblotting or immunofluorescence for endosomal markers. Co-immunoprecipitation experiments can probe disrupted EEA1?CRab5 or EEA1?Csyntaxin 13 interactions, while RT-qPCR can assess transcriptional responses linked to altered trafficking. The cells are also suitable for drug delivery screening campaigns that depend on endocytic uptake and for host-pathogen interaction studies involving intracellular pathogens. Together, these applications establish the EEA1 Knockout AGS Polyclonal Cells as a versatile loss-of-function model for molecular cell biology and translational oncology research. For additional information, please contact Ascent Research.
